Literature DB >> 15637742

Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells.

De-Sheng Xiao1, Ji-Fang Wen, Jing-He Li, Zhong-Liang Hu, Hui Zheng, Chun-Yan Fu.   

Abstract

AIM: To investigate the effect of deleted pancreatic cancer locus 4 (DPC4) gene transfection on biological behaviors of human colorectal carcinoma cells and the role of DPC4 gene in colorectal carcinogenesis.
METHODS: PcDNA3.1-DPC4 plasmid was re-constructed by gene-recombination technology. SW620 cells, a human colorectal carcinoma cell line, were transfected with PcDNA3.1-DPC4 plasmid using lipofectamine transfecting technique. Transfected cells were selected with G418. Expression of Smad4 protein was detected in cells transfected with DPC4 gene by immunohistochemistry and Western blot. Biological characterristics of transfected cells were evaluated by population-doubling time and cloning efficiency. Alterations of percentage of S phage cells (S%) and apoptosis rate were determined by flow- cytometry.
RESULTS: PcDNA3.1-DPC4 plasmid was constructed successfully. SW620 cells transfected with PcDNA3.1-DPC4 plasmid (DPC4+-SW620 cells) showed a strong intracellular expression of Smad4 protein, and the positive signal was localized in cytoplasm and nuclei, mainly in cytoplasm, where the expressions of Smad4 protein in SW620 cells transfected with PcDNA3.1 plasmid (PcDNA3.1-SW620 cells) and non-transfected SW620 cells (SW620 cells) were weaker than those in DPC4+-SW620 cells. The population- doubling time in DPC4+-SW620 cells (116 h) was significantly longer than that in SW620 cells (31 h) and PcDNA3.1-Sw620 cells (29 h) (P<0.01). The cloning efficiencies of DPC4+-SW620 cells (12%) were markedly lower than those of SW620 cells (69%) and PcDNA3.1-Sw620 cells (67%) (P<0.01). Compared with SW620 cells and PcDNA3.1-Sw620 cells, the G0-G1% of DPC4+-SW620 cells was obviously higher and the S% was markedly lower (P<0.05). Apoptosis rate of DPC4+-SW620 cells was significantly higher than that of SW620 cells and PcDNA3.1-SW620 cells.
CONCLUSION: PcDNA3.1-DPC4 plasmid can be successfully re-constructed and stably transfected into human SW620 cells, thereby the cells can steadily express Smad4. DPC4 protein may regulate proliferation of colorectal carcinoma cells by inhibiting cell growth and inducing cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637742      PMCID: PMC4205335          DOI: 10.3748/wjg.v11.i3.348

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.

Authors:  A Maitra; K Molberg; J Albores-Saavedra; G Lindberg
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer.

Authors:  Shin Narai; Masahiko Watanabe; Hirotoshi Hasegawa; Hideki Nishibori; Takashi Endo; Tetsuro Kubota; Masaki Kitajima
Journal:  Int J Cancer       Date:  2002-02-01       Impact factor: 7.396

3.  Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4).

Authors:  Hong-Shan Wei; Ding-Guo Li; Han-Ming Lu; Yu-Tao Zhan; Zhi-Rong Wang; Xin Huang; Jing Zhang; Ji-Lin Cheng; Qin-Fang Xu
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 4.  Gastrointestinal tumorigenesis in Smad4 (Dpc4) mutant mice.

Authors:  M M Taketo; K Takaku
Journal:  Hum Cell       Date:  2000-09       Impact factor: 4.174

Review 5.  [Genetic changes in liver metastasis of colorectal cancer and their clinical application].

Authors:  A Yamaguchi
Journal:  Nihon Geka Gakkai Zasshi       Date:  2001-05

6.  Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.

Authors:  C A Iacobuzio-Donahue; D S Klimstra; N V Adsay; R E Wilentz; P Argani; T A Sohn; C J Yeo; J L Cameron; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

7.  Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.

Authors:  M Koyama; M Ito; H Nagai; M Emi; Y Moriyama
Journal:  Mutat Res       Date:  1999-08       Impact factor: 2.433

8.  Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis.

Authors:  N Ohtaki; A Yamaguchi; T Goi; T Fukaya; K Takeuchi; K Katayama; K Hirose; T Urano
Journal:  Int J Oncol       Date:  2001-02       Impact factor: 5.650

Review 9.  A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway.

Authors:  Shane Holloway; Mishel Davis; Raffat Jaber; Jason Fleming
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 10.  Genetic alterations in pancreatic carcinoma.

Authors:  Gunter Schneider; Roland M Schmid
Journal:  Mol Cancer       Date:  2003-01-22       Impact factor: 27.401

View more
  2 in total

1.  Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial‑mesenchymal transition.

Authors:  Zhenlv Lin; Lin Zhang; Junfeng Zhou; Jiantao Zheng
Journal:  Mol Med Rep       Date:  2019-08-21       Impact factor: 2.952

2.  Retardation of cell growth by avian reovirus p17 through the activation of p53 pathway.

Authors:  Hung-Jen Liu; Ping-Yuan Lin; Jeng-Woei Lee; Hsue-Yin Hsu; Wen-Ling Shih
Journal:  Biochem Biophys Res Commun       Date:  2005-10-21       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.